Clin2
NCT07343024Worth exploringRecruiting

Finding a Personalized Drug for Advanced Cancer

Advanced Cancer

Part of Cancer clinical trials.

This trial looks at whether drugs not usually used for your type of cancer can help you. It matches your tumor's test results to possible treatments and works with your doctor to try one.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must have a genomic or functional test result that suggests a possible drug for your cancer.
  • Your doctor must agree to try a drug that is not standard treatment for your type of cancer.
  • You need a way to pay for the drug, like insurance or covering the cost yourself.
  • You must sign a consent form to take part in the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05159245Recruiting· Phase 2
Targeted drug access for adults with advanced cancer

This trial helps match people with advanced, hard-to-treat cancers to targeted cancer drugs based on lab testing of their tumor. It may help if standard treatment isn’t working or isn’t available, and if your tumor has a “targetable” genetic change.

Turku, Southwest Finland
NCT07346209Not yet recruiting· Phase 2
Personalized cancer treatment trial for advanced solid tumors

This trial tests whether using a personalized approach (matching your tumor's genetic profile to a targeted drug) can help people with advanced solid cancers live longer. It is for people whose cancer is not responding to standard treatments and who have a genetic change that can be targeted by an FDA-approved drug not usually used for their cancer type.

La Jolla, California
NCT05674825Recruiting· Phase 1/Phase 2
Personalized treatment using tumor test results for aggressive cancers

This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.

Milwaukee, Wisconsin
NCT03297606Recruiting· Phase 2
Match your tumor test to a targeted cancer drug

This trial studies whether giving a targeted cancer medicine based on tumor genetic/protein test results can help people with advanced, incurable cancers live longer. You may be eligible if your cancer has a “potentially actionable” change on testing and you meet health and follow-up requirements.

Edmonton, Alberta
NCT06413212Recruiting
Personalized drug test for advanced cancer with fluid buildup

This trial uses a special test on your cancer cells to find which chemotherapy might work best for you. The aim is to treat advanced cancer that has caused fluid buildup in the chest or abdomen.

Wuhan, Hubei
NCT06232213Recruiting
Personalized treatment for relapsed or drug-resistant gynecological cancers

This trial tests a personalized approach to treating advanced ovarian or endometrial cancers that have come back or stopped responding to standard treatments. It uses a special model to guide which therapy might work best for you.

Beijing, Beijing Municipality

Hear when a new Advanced Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.